drugset / Trial / NCT05172999
Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia
RandomizedParallel-groupOpen-labelTreatment
Summary
To study if polyethylene glycol loxenatide plus levonorgestrel-releasing intrauterine system (LNG-IUS) will improve response rates in patients with endometrial atypical hyperplasia.
Timeline
- Start
- 2022-01-08
- Primary completion
- 2025-12-30
- Completion
- 2026-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Loxenatide | Unknown | 0.1 mg | — |
| Subject | Loxenatide | Unknown | 0.2 mg | — |